You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Filters
Status
Categories
- Remove Advertising filter Advertising (2)
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (2) Apply Biologicals filter
- Remove Blood and blood components filter Blood and blood components (0)
- Complementary medicines (7) Apply Complementary medicines filter
- Fees/Payments (1) Apply Fees/Payments filter
- Remove Import/Export filter Import/Export (1)
- Labelling/Packaging (1) Apply Labelling/Packaging filter
- Legislation (3) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (1) Apply Manufacturing filter
- Remove Medical devices/IVDs filter Medical devices/IVDs (55)
- Medical devices safety (1) Apply Medical devices safety filter
- Medicinal cannabis (1) Apply Medicinal cannabis filter
- Remove Medicines filter Medicines (2)
- Medicines safety (1) Apply Medicines safety filter
- OTC medicines (12) Apply OTC medicines filter
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Prescription medicines (7) Apply Prescription medicines filter
- Remove Scheduling filter Scheduling (56)
- Therapeutic Goods Administration (TGA) (2) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (2) Apply Therapeutic goods regulation filter
- (-) Remove Advertising filter Advertising
- (-) Remove Medicines filter Medicines
- (-) Remove Import/Export filter Import/Export
- (-) Remove Blood and blood components filter Blood and blood components
- (-) Remove Scheduling filter Scheduling
- (-) Remove Medical devices/IVDs filter Medical devices/IVDs
Proposed criteria for Appendix M of the Poisons Standard to support rescheduling of substances from Schedule 4 (Prescription only) to Schedule 3 (Pharmacist only)
Closed on 1 April 2019
Proposed regulatory scheme for personalised medical devices, including 3D-printed devices
Closed on 31 March 2019
Proposed reclassification of spinal implantable medical devices
Closed on 31 March 2019
Regulation of software, including Software as a Medical Device (SaMD)
Closed on 31 March 2019
Proposal to introduce a Unique Device Identification (UDI) system for medical devices in Australia
Closed on 18 February 2019
Potential reclassification of active medical devices for diagnosis and patient therapy
Closed on 18 February 2019
Changes to a number of definitions and the scope of the medical device regulatory framework in Australia
Closed on 18 February 2019
Medical device cyber security
Closed on 14 February 2019
Proposed amendments to the Poisons Standard - ACCS meeting, March 2019
Closed on 8 February 2019
Proposed amendments to the Poisons Standard - ACCS, ACMS and Joint ACCS/ACMS meetings, March 2019
Closed on 21 January 2019